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AKTIVITI EKSTRAK SECARA BIOLOGI DARIPADA MAKROALGA 
HIJAU MARIN, HALIMEDA DISCOIDEA 
 
ABSTRAK 
Rumpai laut Halimeda discoidea telah dikaji bioaktivitinya dan pencirian sebatian 
bioaktif yang terlibat. Aktiviti antimikrob ekstrak-ekstrak kasar yang berlainan kutub 
(metanol, etil asetat, dietel eter, butanol, heksana dan kloroform) telah disaring 
terhadap 18 bakteria, tiga yis dan lima kulat melalui kaedah peresapan cakera. 
Didapati, ekstrak heksana telah muncul sebagai ekstrak paling aktif, diikuti dengan 
ekstrak etil asetat (Soxhlet) dan kloroform. Ekstrak heksana mempamerkan aktiviti 
terhadap lima bakteria Gram-positif, tiga Gram-negatif dan dua yis. Kemudian, 
kaedah pencairan kaldu secara makro telah dilaksanakan untuk menentukan 
kepekatan perencatan minimum (MIC) terhadap mikrob yang terencat. Keputusan 
telah menunjukkan nilai MIC dalam julat 0.25 mg/ml hingga 1.00 mg/ml.  Hanya 
empat daripada 13 mikrob yang terencat mempamerkan nilai kepekatan maut 
minimum (MBC) pada nilai 1.00 mg/ml. Profil pertumbuhan bagi Klebsiella 
pneumoniae ATCC 13883, MRSA dan Candida albicans ditentukan untuk 48 jam 
pada kepekatan setengah MIC, MIC dan dua kali ganda MIC. Hasilnya, pada 48 jam 
dan pada kepekatan dua kali ganda MIC, K. pneumoniae ATCC 13883, MRSA dan 
C. albicans masing-masing telah menunjukkan pengurangan kira-kira 1.9 log, 2.3 log 
dan 3.0 log, berbanding dengan kawalan. Mikroskop elektron imbasan (SEM) dan 
mikroskop elektron transmisi (TEM) telah digunakan untuk melihat perubahan 
morfologi sel K. pneumoniae ATCC 13883 dan C. albicans setelah masing-masing 
dirawat dengan ekstrak heksana dan kloroform. Pada kepekatan MIC dan 100.00 
 xx 
 
mg/ml, perubahan morfologi seperti pengecutan dan pemecahan telah diamati pada 
sel-sel yang dirawat. Ekstrak heksana yang aktif disubjekkan kepada fraksinasi 
berpandukan biopencerakinan untuk memencilkan dan mencirikan sebatian bioaktif 
yang terlibat. Fraksi sf2 yang muncul sebagai fraksi aktif dengan nilai kepekatan 
sebanyak MIC 0.50 mg/ml bersama-sama dengan ekstrak kasar telah dianalisis 
melalui kaedah kromatografi gas-spektrometer jisim (GC-MS). Berdasarkan nilai 
peratus kesamaan ≥ 90 % berpandukan piawaian data NIST, dapat diandaikan 
bahawa aktiviti antimikrob telah dicirikan oleh sebatian E-15-heptadekenal. 
Tambahan kepada aktiviti antimikrob, ekstrak-ekstrak telah diperiksa aktiviti 
antioksida, jumlah kandungan fenol, dan analisa unsur-unsur utama, masing-masing 
melalui ujian penjerapan radikal DPPH, Folin-Ciocalteu dan ‘Methods of Analysis of 
Association of Official Analytical Chemists (AOAC)’. Ekstrak kloroform telah 
menunjukkan pencapaian paling tinggi untuk kedua-dua aktiviti iaitu antioksidan dan 
jumlah kandungan fenol. Ujian kemautan anak udang brin telah dijalankan untuk 
menguji tahap akut dan kronik kesitotoksikan  ekstrak heksana dan kloroform. Tahap 
ketoksikan yang agak tinggi telah dicatatkan oleh kedua-dua ekstrak dengan nilai 
kepekatan 50% maut (LC50) pada 30.78 µg/ml untuk heksana dan 96.20 µg/ml untuk 
kloroform. Susunan keputusan analisa unsur-unsur utama daripada yang paling tinggi 
ke paling rendah ialah debu (66.00 ± 1.71) %, fiber (34.52 ± 2.61) %, protein (5.94 ± 
0.03) %, kelembapan (3.21 ± 0.14) %, lemak (1.07 ± 0.14) %. Kesimpulannya, 
ekstrak  tidak   kutub   heksana H. discoidea telah menunjukkan aktiviti antimikrob 
dan kemampuan ketoksikan yang bagus. Selain itu, ekstrak sederhana kutub 
kloroform telah menunjukkan sumber antikandida yang bagus, dan antioksidan 
dengan kandungan fenol yang tinggi.  
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BIOLOGICAL ACTIVITIES OF EXTRACTS FROM GREEN 
MACROALGAE, HALIMEDA DISCOIDEA 
 
ABSTRACT 
Macroalgae Halimeda discoidea was studied for its bioactivities and characterization 
of the bioactive fraction was carried out. The antimicrobial activity of 8 extracts with 
different polarities (methanol, ethyl acetate, diethyl ether, butanol, hexane and 
chloroform) was started with the screening against 18 bacteria, three yeast and five 
fungi, through the disc diffusion method. The result revealed that hexane extract was 
the most active extract, followed by the ethyl acetate (Soxhlet) and chloroform 
extracts.  Hexane extract was active against five Gram-positive and three Gram-
negative bacteria and two yeasts. Then, broth macrodilutan assay was carried out to 
determine the minimum inhibitory concentration (MIC) of all susceptible microbes. 
The results showed that the MIC values were in the range of 0.25 mg/ml to 1.00 
mg/ml. Only four out of 13 susceptible microbes exhibited the minimum bactericidal 
concentration (MBC) of 1.00 mg/ml. The growth profile of Klebsiella pneumoniae 
ATCC 13883, MRSA and Candida albicans were determined for 48 hours at the 
concentrations of half MIC, MIC and double MIC. As the results, K. pneumoniae 
ATCC 13883, MRSA and C. albicans at double MIC showed reductions of 
approximately 1.9 log, 2.3 log and 3.0 log at 48 hours relative to the control, 
respectively. Scanning electron microscope (SEM) and transmission electron 
microscope (TEM) were used to view the morphological changes of the K. 
pneumoniae ATCC 13883 and C. albicans cells treated with the hexane and 
chloroform extracts, respectively. At the concentrations of MIC and 100.00 mg/ml, 
 xxii 
 
morphological modifications such as shrinkage, lysing and breakage were observed 
in the treated cells. The active hexane extract was subjected to the bioassay-guided 
fractionation in order to isolate and characterize the bioactive compounds involved.  
Fraction sf2 that appeared as the active fraction with MIC value of 0.50 mg/ml, 
together with the crude hexane extract were analysed by the gas chromatography-
mass spectrometer (GC-MS) method. Based on the basis of ≥ 90 % match with the 
NIST standard reference data and literature evidences, it be suggested that the 
antimicrobial activity of H. discoidea was attributed by the compound E-15-
heptadecenal. In addition to the antimicrobial activity, the extracts were also 
investigated for their antioxidant activity, total phenolic content and proximate 
analysis through the DPPH-scavenging assay, Folin-Ciocalteu assay and methods of 
Analysis of Association of Official Analytical Chemists (AOAC), respectively. 
Chloroform extract showed the highest result for both antioxidant and total phenolic 
content. Brine shrimp lethality test was carried out to determine the acute and 
chronic cytotoxicity level of hexane and chloroform extracts. Relatively high of 
chronic toxicity level was recorded by both extracts with LC50 values of 30.78 µg/ml 
for hexane and 96.20 µg/ml for chloroform. As for the proximate analysis, the order 
of the component from the major to the least was ash (66.00 ± 1.71) %, fibre (34.52 
± 2.61) %, protein (5.94 ± 0.03) %, moisture (3.21 ± 0.14) % and lipid (1.07 ± 0.14) 
%. In conclusion, the non-polar hexane extract of H. discoidea showed promising 
antimicrobial activity and toxicity potential. In other hand, the medium polarity of 
chloroform extract of H. discoidea showed good source of anticandida and 
antioxidant activities with high phenolic content.  
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CHAPTER 1.0 INTRODUCTION 
 
1.1    Discovery of seaweed-derived drugs 
 
Natural products derived from both terrestrial and marine organisms play a crucial 
role in the treatment of ailments since time immemorial (Smit, 2004; Vishwanathan 
and Basavaraju 2010; Alzweiri et al., 2011). The biological properties of these 
natural products such as; antibiotic for microbial infections, antioxidant agent to 
combat free radicals, antiviral and anticancer agents have been widely reported. As 
for the antibiotic purpose, the controls of bacterial and fungal infections have been 
remarkably effective since the discovery of Bacillus anthracis to cure the anthrax 
disease during 1877. Research on natural antibiotic has expands and many plant-
derived antimicrobial drugs have been successfully isolated (Dorman and Deans, 
2000; Duraipandiyan  et al., 2006) 
 
Unfortunately, together with this increment is the rise of multidrug-resistant 
pathogens (Wright, 2005; Theuretzbache, 2009). The phenomenon of drug resistance 
grows drastically and has become a serious problem than expected. The improper use 
of antibiotic has triggered the microbes to be genetically mutant and no longer 
susceptible to the drugs used.  Therefore, the search for new antibiotic is targeted at 
new target such as the marine organisms, especially the seaweeds. The great 
diversity of seaweeds in the oceans represents inexhaustible sources of highly 
bioactive secondary metabolites, awaiting to be discovered.   
 
Seaweeds, also known as macroalgae are being utilized as a food source and as 
traditional remedies by the people from many parts of the world since long time ago. 
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However, the revolution of macroalgae usage has increased significantly especially 
in the extraction of the macroalgae‟ compounds. The extraction of compounds from 
the seaweeds has started with the extraction of agar, carrageenan and alginate that are 
used as industrial products. Since then, scientists started to search for other 
compounds from the seaweed that are also biologically active.  As the attention has 
shifted to the seaweeds, many biologically active secondary metabolites have been 
isolated and evaluated for their bioactivities from all over the world (Smit, 2004).  
Different seaweeds form different divisions; Chlorophyta (green macroalgae), 
Rhodophyta (red macroalgae) and Phaeophyta (brown macroalgae) have shown to 
possess selective or multiple bioactivities. One of them is the sulphated 
polysaccharides from red macroalgae Aghardhiella tenera that shows antiviral 
activities towards human immunodeficiency virus (HIV) and Herpes simplex virus 
(HSV) (Witvrouw et al., 1994). Another example is the compound Kahalalide F that 
that was isolated from the green macroalgae Bryopsis sp. that exhibited multiple 
bioactivities including the anticancer, antitumor, and antiviral activities (El Sayed et 
al., 2000).  Almost all brown algae contain phlorotannins, phenolic compound that is 
very effective as the antioxidant agent. For example, the fucols in Fucus Vesiculosus 
(Koivikko et al., 2007) and eckols in Eckonia stolonifera (Kim et al., 2009).   
 
The discovery of effective bioactive compounds from the macroalgae has brings 
hope to the pharmaceutical field.  The occurrence of highly diverse macroalgae‟ 
secondary metabolite is closely related with the ability of the macroalgae to survive 
in the habitat. 
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1.2 Selection of macroalgae for drug discovery 
 
More than 8000 species of macroalgae inhabit the oceans and coastlines of the earth 
(www.seaweed.ie).  It is a fact that different macroalgae floras grow at different 
oceans based on their habitat suitability and the climate zones. Malaysia is a small 
country that is situated near the equator and is surrounded by South China Sea, 
Pacific Ocean and Andaman Sea hence experiencing the tropical climate that is hot 
and humid throughout the year. The variety in the type and distribution of Malaysia 
macroalgae is influenced by the rains and tides caused by the monsoon wind 
systems, the Northeast Monsoon and Southeast Monsoon that blow at different times 
of the year (Phang, 1998).   
 
The study on Malaysia‟s macroalgae has started since 1984 (Phang, 1984), and 
according to Du et al., (2008), the distribution checklist has been updated by Phang 
in the following years (1994, 1998, 2006, 2007). There were also some other field 
works reported on the distribution of the macroalgae at particular locations, such as 
the Port Dickson (Mijan Uddin et al., 2007), Straits of Malacca (Phang et al., 2008) 
and Johor (Gan et al., 2011). Based on the published data, the highest taxa is 
conquered by the red algae group (Rhodophyta), followed by the green algae 
(Chlorophyta) and lastly the brown algae (Phaeophyta).  Despite of the increasing 
records on the distribution and ecology of the macroalgae, the study on the 
phytochemical compounds and the bioactivities of these Malaysia macroalgae had 
received little attention and still very low in number. Additionally, the existed 
bioactivity studies of the macroalgae were only emphasized on the edible macroalgae 
such as Gracilaria changi (Sasidharan et al., 2009), Acantophora spicifera (Nurul 
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Aili et al., 2010), Euchema denticulatum (Al-Haj et al., 2009; Matanjun et al., 2009), 
Laurencia spp (Vairappan et al., 2008; Vairappan et al., 2010), Caulerpa lentillifera 
and Sargassum polycystum (Matanjun et al., 2009).  Out of 373 specific and 
intraspecific taxa that has been identified (Phang et al., 2007), the species that have 
been studied represent a very small part of the Malaysian macroalgae. Despite of the 
large macroalgae community in Malaysia, the attention is always on the edible 
species. Therefore the inedible species are underutilised. One of them is from the 
genus Halimeda sp., including Halimeda discoidea Decaisne. This species can be 
found in many parts of the world oceans; Pacific Ocean (Fenical and Paul, 1984), 
Bahamas and the Great Barrier Reef (Verbruggen et al., 2007), Australian coast 
(http://florabase.dec.wa.gov.au), Arabian Sea (Sohrabipour and Rabiei, 2007) and 
Mediterranean (Braga et al., 1996), Caribbean Sea (Fenical and Paul, 1984) 
 
In Malaysia, the species in the family Halimedaceae‟ is consists of Halimeda 
discoidea, H. macroloba, H. opuntia, H. simulans and H. tuna and is widely 
distributed at the Sabah, East and West coast of Peninsular Malaysia (Phang, 2006).  
There is neither nutritional value nor industrial value that has been recorded 
regarding to this macroalgae, except it is only being used as fertilizers for the soil 
amendment to make the soil less acidic (www.wildsingapore.com). However, there 
are reports on some bioactivities of this Halimeda genus, including the antimicrobial 
activity (del Val, 2001; Karthikaidevi et al., 2009), antioxidant activity (Zubia et al., 
2007; Boonchum et al., 2011) and toxicology (Paul and Hay, 1986). The production 
of secondary metabolites of Halimeda sp. was noted to contribute to these 
bioactivities. Nevertheless, the isolation of the bioactive compound from Halimeda 
sp. is still limited as until now, only halimedatetraacetate and halimedatrial (Paul et 
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al., 1998a) that have been isolated and recognized as biologically active. There have 
been a number of reports of antibiotic activity of the Halimeda spp. However, for the 
most part these reports represented the preliminary studies of crude extracts and little 
follow-up work has been done to isolate the bioactive compounds.  Since the 
bioactivities and compounds characterization of this Halimeda sp. is still scarce, 
therefore this species was selected to be studied. This species also could be the 
source of new compounds with highly potential bioactivities.  
 
1.3 Problem statements 
 
Investigation pertaining to the bioactivities of Halimeda spp. from various locations 
has been recorded, but the one that originates from Malaysia especially in the 
antimicrobial activity is still very limited. Therefore, the aim of this study was to 
evaluate the bioactivities of a species from the genus Halimeda, namely Halimeda 
discoidea as the antimicrobial and antioxidant agents, together with the information 
on its toxicity property, phenolic content, analysis of the chemical compounds of the 
extract and the proximate analysis. This study may provide excellent information on 
the biologically and chemically leads for the discovery of new drugs.  
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1.4 Objectives of research 
 
The objectives of this study were: 
1. To extract the bioactive compounds of Halimeda discoidea using various 
organic solvents and to screen the antimicrobial activity of its crude extracts  
against a series of pathogenic clinical and ATCC bacterial, yeasts and fungal 
cultures. 
  
2. To study the effect of the extracts on the growth of microorganisms and their 
morphological changes, and also to determine the cytotoxicity against the 
brine shrimp, Artemia salina. 
 
3. To determine the antioxidant activity, total phenolic content and proximate 
analysis of the Halimeda discoidea crude extracts. 
 
4. To isolate and identify the bioactive compound with antimicrobial activity 
from the most active extract of Halimeda discoidea.  
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CHAPTER 2.0 LITERATURE REVIEW 
 
2.1 Natural products as the healers 
 
For thousands of years, traditional medicine practitioners have been using the natural 
products of plants and animals to treat the sick people. The term natural product is 
applicable for any biological molecule of the living organisms, but it is usually 
referred as the secondary metabolites that is produced for the defense mechanism, 
regulator molecules or as the result of nutrient limitation.  Natural products exhibit 
many biological properties including the antibiotic for microbial infections, 
antioxidant agent to combat free radicals, antiviral and anticancer agents. The 
chemical studies of the natural products has begun in the year 1877, when Louis 
Pauster found the right treatment to cure the anthrax disease, by introducing the 
Bacillus anthracis strain to the infected animal. The emergence of natural product 
antibiotic continued with a finding by Rudolf Emmerich in 1890s that showed 
cholera infection can be treated with a medication called pyocyanase from microbes 
After that, penicillin from the mould Penicillium notatum was found to inhibit the 
growth of Staphylococcus aureus. The trend of searching for healer from natural 
product has shifted to the plant. All higher plants are capable to produce secondary 
metabolites as their common defence weapon to fight off herbivorous animals and 
microbial infections (Sirikantaramas et al., 2008). Those secondary metabolites turn 
out to be the crucial substances for developing natural-derived drugs. For example, a 
plant-derived drug named curcumin from Curcuma longa is used to treat 
gastrointestinal upset and arthritic pain. Taxol and teniposide that are isolated from 
Taxus brevifolia and Podophyllum peltatum, respectively are used as antitumor 
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agent. Over the last few years, more plant-derived compounds with antimicrobial 
activity have appeared in the literatures (Dorman and Deans, 2000; Duraipandiyan  et 
al., 2006).  
 
2.2 Antimicrobial agent and the need for new discoveries 
 
The golden era of effective antibiotic therapy such as penicillin, cephalosporin, and 
streptomycin against pathogenic microbes has sunk slowly with the rise of new 
resistant strains. The need for new antimicrobial agents has become a major public 
health concern nowadays. The underlying factors of this phenomenon are the 
emergence of new diseases caused by the  multidrug-resistance microbes and lack in 
the production of new functional antimicrobial drugs. 
 
 Within the past half century, many scientific journals and articles seem to report the 
discovery of wide variety of antimicrobial compounds (Rivero-Cruz, 2008, Al-
Bayati, 2009; Arifuzzaman et al., 2010; Engelhardt et al., 2010). Academic 
researchers, biotechnology industries and pharmaceutical companies have been 
struggling to isolate, design and synthesize the new potential compounds and tested 
them against the top listed infectious microbes. Unfortunately during the 1990s, 
many pharmaceutical companies have withdrawn themselves from this antibiotic 
field because of some reasons (Projan, 2003; Norrby et al., 2005). All these efforts 
were done in order to fulfil the unmet medical needs and to reduce the percentage of 
morbidity and mortality caused by these aggressive strains.  Although there are many 
new compounds from various sources have been isolated and screened for their 
antimicrobial properties, only small part of them passed the clinical trial phase. 
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Drugs that enter clinical trial have to go through some complicated procedures with 
high qualification standard and sometimes some of them are lack of vital information 
(Lunde, 1990; Manheimer and Anderson, 2002). Hence, this hurdle does restrain the 
new promising antimicrobial drugs from being marketing out there.   
 
Starting late 20
th
 century up to the beginning of 21
st
 century, the emerging of new 
infectious diseases has emerged regularly and caused chaotic to the mankind. The 
rate for this appearance is at the average of one disease per year (Rincon, 2006).  The 
emergence of new infectious diseases can be defined as the increment of new human 
diseases that are caused either by the introduction of new agent to the existed 
unrecognized agent or due to the demographic and environmental changes 
(Lederberg et al., 1992).  New diseases that appeared not only focus on the bacteria 
alone, but it also involves viruses and parasitic agents. The current examples of 
emerging diseases are such as HIV/AIDS, Lyme diseases, food borne diseases cause 
by some Escherichia coli strains, severe acute respiratory syndrome (SARS) and 
Spanish flu (Woolhouse and Antia, 2008). 
 
A series of factors are causing this life-threatening phenomenon. One of them is the 
ecological changes for the agricultural development and economic purposes (Patz et 
al., 2004). People who work in environments such as the land, farm, forests and 
swamps are actually at risk of being infected. The interaction between the people and 
the environment somehow unintentionally exposed them to the infective agents 
(Morse, 1995). Nature disasters like flood and drought which involves water and 
weather are always associated with the dissemination of infections to others. For 
example, the Korean hemorrhagic fever among the farmers that is caused from the 
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contact of infected field mouse Apodemus agrarius with a virus called Hantaan to the 
farmers (Nathanson and Nichol, 1998). 
 
It has been suggested that demographical changes and human behaviours also 
contribute to this new disease outbreaks. Migrated people including refugees, 
students, pilgrims and immigrants have the potential to unconsciously bring along 
the inactivated virus that present within them to the new place (Wilson, 1995). This 
will bring the local hosts into contact with the survived pathogens and may become 
epidemic. Besides, the lifestyle of people has a great influence in the emergence and 
re- emergence of diseases. Crowded places like day care centre, swimming pool and 
recreational park are the focal point of distributing contaminated water. People who 
go there can easily acquire the contaminated water and plagues will start to spread 
(Macpherson, 2005).    
 
Sometimes new diseases arise because of the microbial adaptation itself. Evolving 
microbes have the ability to be resilient and adaptive to the unfavourable surrounding 
like scarcity in nutrient supply, climate changes and the presence of antimicrobial 
compounds that purposely introduced to kill the microbes (Alanis, 2005). Of them, 
the resistance with antibiotic problem has received a great attention worldwide (Van 
der Waaij and Nord, 2000; Haeno and Iwasa, 2007; Vonberg et al., 2008). 
Inadequate or over use of antibiotics during the antibiotic therapy has exposed the 
microbes to the antibiotics thus giving them chance to learn and adapt to the 
mechanism of action of the antibiotics (French, 2005). They are not only evolved to 
be resistant to the antibiotics but they also could remain alive in the hospital and 
infect high risk group including the neonates and immune suppressed persons.  
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2.3 Antibiotics 
 
Originally, antibiotic is defined as microbial metabolites with low-molecular weight 
substances that are capable to inhibit the growth of other microorganisms at low 
concentrations. However the definition has changed when the sources of antibiotics 
such as plant products with chemically modified natural antibiotics (semi synthetic) 
and synthetic products emerged. The modified version of this antibiotic definition 
now is any natural product or a substance that 100% or partly produced by chemical 
synthesis of the natural products that can inhibit the growth of other microorganisms 
at low concentrations (Russell, 2004). Antibiotics are classified according to the 
main groups of microorganisms they inhibit; for instant antibacterial, antifungal and 
antiviral antibiotics. The antimicrobial therapies of an antibiotic are divided into two 
broad groups, which is bactericidal and bacteriostatic.  It is bactericidal when the 
microbial inhibition is irreversible, meaning that the infecting microorganism is 
killed permanently and it is bacteriostatic when the microbial inhibition is reversible, 
meaning that the growth is impaired temporarily (Lancini et al., 1995a) 
 
2.3.1 Antibacterial antibiotic and its mechanism of actions 
 
There are various mechanisms of actions possessed by the antibiotics and this 
depends largely on the antimicrobial compounds of the antibiotics and their target 
macromolecules of the microorganisms. Once the active compound managed to 
reach the site of action that usually involved in cell‟s routine function, it will inhibit 
the metabolic process and eventually cause the cell to be malfunctioned and die.  
Antibiotics that have same basic chemical structures are grouped together and 
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different groups will perform different kind of actions in inhibiting the microbial 
growth. Mechanisms of actions of the antibiotics are such as inhibiting the cell wall 
synthesis, transcription, replication, translation, membrane synthesis and function 
and as antimetabolites (Lancini et al., 1995b). Major types of antibiotics based on the 
chemical structures and the examples of each type are  summarized  in  Table 2.1. 
 
Table 2.1: Classification of main antibacterial antibiotics and the mechanism of 
                 actions (Yuri, 2010)         
 
Antibiotics Examples   Mechanism of actions 
Penicillins  Ampicillin and amoxicillin Inhibit cell wall formation 
Cephalosporins  Cephalothin, cefazolin, ceforanide, 
cefuroxime, cefpodoxime cefozopran 
 
Inhibit cell wall formation 
Fluoroquinolones 
 
 
Tetracycline  
Ciprofloxacin, levofloxacin, 
lomefloxacin, norfloxacin 
 
Tetracycline, doxycycline, 
minocycline, oxytetracycline. 
Interfere with nucleic acid 
replication and transcription 
 
Inhibit protein synthesis 
 
 
Macrolides  Clarithromycin, azithromycin, 
roxithromycin, troleandomycin 
Inhibit protein synthesis 
   
 
 
2.3.1.1 Disruption of microbial cell wall 
 
The first two β-Lactam antibiotics are known as penicillins (penicillin G and 
penicillin V) and cephalosporins (cephalosporin C), and both of them originated 
from the Penicillium notatum  and Cephalosporium sp. respectively. This antibiotic 
is named based upon its basic chemical structure, which is the four-membered β-
lactam ring and the structure of the second ring is the one that determine either it is 
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penicillin or cephalosporin. This structure is responsible in disrupting the synthesis 
of peptidoglycan, the vital component of the cell wall of all bacteria by interacting 
with the transpeptidase or d-carboxypeptidases (Weil et al., 1995; Lambert, 2004; 
Silver, 2006).  Cell wall is a network of rigid structure called peptidoglycan and 
other macromolecules like polysaccharides and lipoproteins and its function is to 
maintain the shape and bear the high internal osmotic pressure of the cell. The 
percentage of peptidoglycan that presents in the cell wall of Gram-positive bacteria is 
higher than the one in Gram-negative bacteria (Scheffers and Pinho, 2005) and this 
explains the varying degree of sensitivity of different bacteria towards different β-
lactam antibiotics. Once the cell wall being distorted, the high cytoplasm osmotic 
pressure of the cell will cause the cell‟s shape to deform and burst to death.  
 
2.3.1.2 Inhibition of outer membrane synthesis 
 
An outer membrane is a part of plasma membrane structure that only presents in the 
Gram-negative bacteria and it is located at the outermost part of the cell. The 
interaction between the two major macromolecules in the cell membranes which is 
phospholipids and lipopolysaccharides serves as the protective barrier against 
harmful substances, including antibiotics. Unfortunately, antibiotics such as 
polymyxins and its derivatives are more susceptible to Gram-negative bacteria such 
as Pseudomonas aeruginosa, Escherechia coli and Klebsiella spp..(Behera et al., 
2010; Falagas et al., 2010). It is because as the antibiotic is highly attracted to the 
outer membrane than the inner membrane. The selective activity of the antibiotics 
against Gram-positive and Gram-negative bacteria is because of the existence of this 
outer membrane. 
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2.3.1.3 Inhibition of protein synthesis 
 
Ribosome plays the role as the central unit for protein synthesis of both prokaryotic 
and eukaryotic cells and organelles. Antibiotics act on the protein synthesis at three 
different stages; distorting ribosomal binding sites (Franceschi and Duffy, 2006; 
Murray et al., 2006), inhibiting the production of aminoacyl-tRNA (Kirillov et al., 
1997) and interfering with the elongation factors of the ribosome (Landini et al., 
1993; Collignon and Turnidge, 1999). Examples of antibiotics that inhibit protein 
synthesis are such as mupirocin, streptomycin, cloramphenicol, erythromycin, fusidic 
acid and elfamycins.   
 
2.3.1.4 Inhibition of nucleic acid replication and transcription 
 
Deoxyribonucleic acid (DNA) is the most important macromolecule for all living 
things. However, the macromolecule can be interfered by antibiotics such as 
fluoroquinolones, sulphonamides, rifampicin and nitroimadazoles. Fluoroqinolones 
and rifampicin are the antibacterial agents that inhibit the synthesis of some essential 
enzymes for the DNA synthesis (Smith et al., 2001; Tupin et al., 2010). The 
analogues of antibiotics such as sulphanomides can act as the inhibitors of nucleic 
acid polymerization (Stokstad and Jukes, 1987) while reduced nitroimadazoles can 
cause the breakage of the DNA strand (LaRusso et al., 1977).  
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2.3.1.5 Antimetabolites 
 
Antimetabolite antibiotic interferes with the bacterial metabolic pathway by having 
similar structure as the natural metabolites, thus they compete with each other in 
order to bind to the natural metabolite‟s binding site. Once the binding site is 
wrongly accommodated by the antimetabolite, the metabolic pathway will be 
alternated and the normal process is inhibited. There are two types of antimetabolites 
based on their mechanism of actions. The first type is having the same chemical 
structure like other essential constituent thus inhibit the  synthesis of other essential 
macromolecules, such as nucleic acid (Talwar and Srivastava, 2003).  The second 
mechanism of action involves the fusion of antimetabolites during the 
polymerization of macromolecules such as DNA, RNA, and proteins (Sitaram and 
Nagaraj, 1999). 
 
2.3.2 Antifungal antibiotic and its mechanism of actions 
 
Fungi and yeast are the microorganisms of eukaryotic group and are classified under 
the same group with other higher level organisms. Sufficient actions of the antifungal 
agents against targeted macromolecules of the fungi will lead to death of the fungi. 
This will permanently or temporarily combat the growth of harmful fungal infections 
of the hosts.  Despite of the successful development of many new antifungal drugs, 
the therapeutic failures on the fungal infections also keep on appearing dramatically. 
The number of life-threatening fungal infections such as the aspergillosis and 
candidosis caused by Aspergillus sp. and Candida sp. respectively among 
immunocompromised patients showed an upward trend for the past two decades 
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(Díaz-Fuentes et al., 2001; Slavin et al., 2001; Pierrotti and Baddour, 2002).  
Antifungal antibiotics work through several mechanism of actions, which is 
inhibiting the fungal cell wall or plasma membrane formation, inhibiting the 
synthesis genetic materials and disruption their mitotic pathway (Borgers, 1980; 
Odds, 2003). Table 2.2 shows the classification of main antifungal antibiotics and 
their mechanism of actions.  
 
Table 2.2: Classification of main antifungal antibiotics (Gupte et al., 2002) 
Antibiotics Examples   Mechanism of actions 
Polyene 
 
 
Azoles  
Amphotericin B, Nystatin 
 
 
Miconazole, 
Ketoconazole, 
Fluconazole, Variconazole 
Disrupting the ergosterol 
of the cell membrane 
 
Disrupting the sterols/ 
ergosterols of the cell 
membrane 
 
Allylamine and 
thiocarbamate 
 
 
Morpholine  
 
 
Nucleoside analogue  
Naftifine, Terbinafine, 
Tolnaftate 
 
 
Amorolfine 
 
 
5-Fluorocytosine (5FC) 
Disrupting the ergosterol 
of the cell membrane 
 
Inhibit sterol synthesis 
component  
 
 
Inhibit DNA synthesis 
 
 
 
2.3.2.1 Inhibitors of fungal cell wall synthesis 
 
The fungal cell wall that serves as protective barrier and support to fungi‟s cellular 
organelles is always the target of host immune system and antibiotics during the 
fungal infection. In filamentous fungi such as Aspergillus fumigatus and yeast like 
Candida albicans, the cell wall‟s constituents are the chitin and the mixture of β-
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glucan (Sanjuán et al., 1995; Bernard and Latgé, 2001; Netea et al., 2006;). This 
uniqueness makes the fungal cell wall to be easily targeted and destroyed by the 
antibiotics. Echinocandins is an example of antifungal that will disrupt the 
production of (1,3)-β-D-glucan synthase enzyme of the cell wall and caused 
disruption in the cell wall (Debono and Gordee, 1994; Deresinski and Stevens, 
2003). Another promising target of antifungal drugs on the cell wall is the chitin. 
Polyoxins and nikkomycins inhibit the synthesis of enzyme chitin synthetase in 
fungal (Endo et al., 1970; Li and Rinaldi, 1999).  
 
2.3.2.2 Disruption of chromosome function and replication 
 
The antifungal agent called 5-fluorocytosine has been shown to have inhibition 
activity in some fungi (Waldrof and Polak, 1983; Pfaller et al., 2002; Paluszynski et 
al., 2008). 5-fluorocytosine exerts its antifungal effect by inhibiting the thymidylate 
synthetase activity and synthesizing 5-fluoro-2‟-deoxyuridylic acid causing an 
impairment of DNA synthesis (Fisher and Zaoutis, 2008) 
 
2.3.2.3 Disruption on the membrane structure 
   
Ergosterol (predominant sterol) and other sterol compositions are important 
macromolecules in the formation of fungal cell membrane (Mysyakina et al., 2002; 
Weete et al., 2010). These cell membrane components are vital to maintain the 
cellular functions thus allowing the fungi to survive and proliferate.  The alteration of 
the membrane structure occurred when polyene and its members such as 
amphotericin B and nystatin bind to the membrane sterols of the fungal, resulting in 
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channels formation and loss of inner cell‟s molecules (Lancini et al., 1995b). The 
presence of lipophilic site of the antibiotic and lipophilic site of the fungal sterol ring 
within the membrane caused them to be highly attracted to each other (Kaneshiro, 
2002; Hac-Wydro and Dynarowicz-Latka, 2006). Azoles are another type of 
antifungal drugs that derive their action towards the membrane cells.  
 
2.3.2.4 Inhibition of fungal cell mitosis  
 
The diseases caused by superficial mycoses on the skin, hair and nails are usually 
treated with the fungicidal agent griseofulvin, orally (Hector, 2005). Griseofulvin is 
one of the earliest antifungal products extracted from the Penicillium griseofulvum. 
The mechanism of action for this type of drug is based on the disruption of the 
assembly of microtubules in the fungal cell (Rezanka and Spízek, 2005) as well as 
the microtubules‟ cytoplasmic content (Bossche et al., 2003) and thus inhibiting the 
fungal cell mitosis pathway.   
 
2.4 Antioxidant 
 
Reactive oxygen species (ROS) or free radicals can be defined as derivatives of 
oxygen molecules with one unpaired electron (Turrens, 2003). A free radical is 
formed during the redox reaction of a molecule whereby one electron is removed 
from the paired electron and caused the molecule to become unstable and very 
reactive.  A complete redox reaction of oxygen will produce water molecule and also 
some by-products, which are the ROS.  Normal metabolic pathways of living 
organisms will generate free radicals and other ROS like hydrogen peroxide and 
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hypochlorite ions that tend to attack other molecules (Langseth, 1995). The most 
common occurrence reason of oxidation process in living things are due to the 
photosynthesis in plants (Dummermuth et al., 2003) and aerobic respiration system 
(Pham-Huy et al., 2008). 
 
In aquatic plants, intense light illumination and high salt intensity will result in 
excessive ROS production and this can be a threat to the cells. Free radicals are very 
reactive and can rapidly attack lipids, carbohydrates, DNA and other protein 
molecules of nearby cells (Pietta, 2000). Damages to the functioning cells later on 
will cause chronic diseases such as cancers, coronary heart disease, Alzheimer and 
Parkinson (Nabatchian et al., 2004; Gu et al., 2005; Butterfield et al., 2006; Pham-
Huy et al., 2008). Antioxidant is needed to counter act the oxidation process by 
slowing down or completely terminate the process. Antioxidants are the reductive 
agents that act on the oxidants thus inhibiting the oxidation of other substances (Vaya 
and Aviram, 2008).  
 
Cells in human are protected by two defensive systems against these ROS, which are 
the endogenous and exogenous antioxidants. Endogenous antioxidants that naturally 
present in the body are divided into two; enzymatic antioxidants, including 
glutathione peroxidases, superoxide dismutases and catalase, (Langseth, 1995) and 
also non-enzymatic antioxidant, including α-tocopherol (vitamin E), β-carotene, 
ascorbate (vitamin C), and glutathione (Droge, 2002). Incomplete protection of 
endogenous antioxidants is covered by the antioxidants from the outside source, 
which is known as exogenous antioxidants. Exogenous antioxidants, such as vitamin 
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A, C, E, polyphenols and carotenoids are obtained through the daily food 
consumption (Pietta, 2000).  
 
Knowing that antioxidant compounds are crucially needed to maintain a healthy 
body, the demand and production of synthetic antioxidants has gone apace across 
time. Buthylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), propyl 
gallate (PG), octyl gallate (OG) and dodecyl gallate (DG) and quacertin are the 
examples of synthetic antioxidants and they are known to have better activity than 
natural antioxidants. However, consumers are more preferred to consume natural 
antioxidants than synthetic one, concerning to the safety issues of the synthetic 
products (Botterweck et al., 2000; Pokorný, 2007). Epidemiological and clinical 
studies on plant-based foods such as vegetables, fruits and medicinal plants has 
proved that terrestrial plants are rich with antioxidants compounds (Auddy et al., 
2003; Saha et al., 2004; Montoro et al., 2005).  
 
2.5 Bioactive compounds from marine sources 
 
Marine products have been appreciated by the mankind since many years ago. Back 
then, the usage of the marine products is only based on the understanding that this 
particular marine organism can heal the ailments and is passed down to the next 
descendents. No one knows the exact mechanism that underlies the treatment. The 
failures of existed antibiotics in killing resistance microbes have inspired the 
researches to search for the bioactive compounds from various sources, including the 
oceans. The expanding interest in marine-derived bioactive compounds has somehow 
reduced the criticalness of the antibiotic-resistant dilemma. 
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The large area covers by the oceans on this earth has contributed to the rich diversity 
of marine organisms and habitats, and thus encompass a wide variety of chemical 
classes. Eventhough a huge number of marine-derived drugs with various biological 
activities such as antiviral, anticancer and antibacterial have been discovered and 
discussed in the past few decades (Scheuer, 1973; Fusetani, 2000; Pomponi, 2001), 
but there is still enormous numbers of species remained unexplored. Stressful marine 
environment with less light, high pressure, extreme coldness and the presence of 
preys have induced the organisms to develop special morphological and chemical 
weapons to go against the stress. The toxic chemicals compounds have been utilized 
by the organisms to inhibit the vital metabolic process in the prey, predators and 
competitors. These compounds seemed to serve as highly potent candidates with 
promising bioactivities for the discovery of new drugs. Bacteria, fungi, macroalgae 
and marine invertebrates are the sources for the so-called marine natural products. 
Table 2.4 shows some examples of compounds isolated from marine organisms with 
their bioactivities (Donia and Hamann, 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 22 
 
Table 2.3: Bioactive compounds from marine organisms and their classifications  
                 (Donia and Hamann, 2003) 
 
Compound  Type  Source 
Antibacterial activity 
Bromosphaerone 
 
 
Jorumycin  
 
 
Cibrostatin 3 
 
 
Pestalone  
 
Bromoditerpenes  
 
 
Dimeric isoquinoline 
alkaloid 
 
Isoquinolines  
 
 
Chlorinated benzophenone  
 
Sphaerococcus 
coronopifolius (red alga) 
 
Jorunna funebris (sea 
slug) 
 
Cribrochalina sp. 
(sponge) 
 
Rosenvingea sp. (brown 
alga) 
 
Antifungal activity 
Halishigamide A 
 
Phorbaxazole B 
 
Bengazole A 
 
 
Meridine  
 
Macrolide  
 
Macrolide  
 
Oxazole-containing fatty 
acid ester 
 
Polycyclic alkaloid  
 
Halichondria sp.(sponge) 
 
Phorbas sp. (sponge) 
 
Jaspis sp. (sponge) 
 
 
Corticium sp. (sponge) 
 
Antiviral activity 
Thyrsiferol  
 
Gymnochrome D 
 
 
 
 
Spongiadol  
 
Triterpene  
 
Brominated 
phenanthroperylenequinone 
 
 
 
Tetracyclic furanoditerpene  
 
Laurencia venusta (red 
alga) 
 
Gymnocrinus richeri 
(pigments from fossil 
crinoids) 
 
Spongia sp.  
 
Antiprotozoal activity 
Plakortide  
 
 
Cyclic peroxides  
 
Cyclic peroxylactone  
 
 
Peroxide  
 
 
Plakinastrella onkodes 
(sponge) 
 
Plakortis aff 
angulospiculatus 
(sponge) 
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2.5.1 Marine macroalgae  
 
Macrolagae or seaweed is the marine plant, photosynthesizing multi-cellular 
organisms that lack specialized structures and mechanisms for reproduction. The 
main structure of a macrolagae consists of thallus, blades, pneumatocysts, stipe and 
holdfast.  Macrolagae is divided into three major groups based on their different 
photosynthetic pigments found in their cells; green algae (Phylum Chlorophyta); 
brown algae (Phylum Phaeophyta); red algae (Phylum Rhodophyta). They usually 
attach to the surface of the rocky shores and reef, shells or any hard surface using 
their holdfasts. Macrolagae have the role to balance the ecosystem as the primary 
producer in the aquatic world. They directly use energy from sunlight for 
photosynthesis and produce oxygen for others and also serve as one of the food 
source. Besides, the existence of macroalgae in the oceans will aid in filtering the 
oceanic nitrate and ammonium produced by the invertebrates for the nitrogen fluxes 
that later will be utilized by other marine organisms (Bracken and Stachowicz, 
2006). The variation in distribution of different macroalgae species have been 
studied in various oceans‟ areas and the data showed the algal growth is strongly 
related to the biotic and abiotic factors such as the grazer‟s population, seasons, 
elevation of the habitat, and nutrient supply (Eriksson and Bergstrӧm, 2005; 
Thomsen et al., 2006; Kerswell, 2006).  
 
Algae have been consumed by the people in certain countries since long ago because 
of the high mineral and nutrient contents. For example, “Nori” or Poryphyra sp. that 
being consumed by the Japanese since 300 years ago is proven to contain high 
content of soluble dietary fibre that can lower the glycemic index in human (Goñi et 
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al., 2000). Increase in demand of this species locally and internationally has 
contributes to the inflation of Japan economic growth, with approximately more than 
2 million U.S. dollars per year (Barsanti and Gualtieri, 2005). In Malaysia, some 
communities who live at the coastal areas consume Gracilaria changii, Gracilaria 
tenuispitata, Euchema sp. and two Caulerpa spp as their salad course (Phang, 2006). 
Exploitation of macrolagae properties have been extended into the food industry. 
Rhodophyta Euchema spp are specially cultivated in some Asian countries to obtain 
the agars and carrageenans (hydrocolloids) (Phang, 2006). These two components 
are extracted from the species and are used in the food technology as the gelling and 
thickening ingredients in food products 
(http://www.seaplants.co.cc/2009/11/eucheuma-seaplants-in-indonesia.html).  
 
2.5.1.1 Marine macroalgae with medicinal properties 
 
Macroalgae is another important source of potential bioactive compounds for the 
marine-derived drugs. The bioactive compounds are the secondary metabolites 
produced by the algae, as the chemical weapons to survive in the marine ecology. 
The  marine  ecology  is  full  of  stresses  like  intense  competitions  for  space, 
combinations of high UV radiation and oxygen level, high salinity, attack from the 
grazers and desiccation during high temperature (Smit, 2004). Algae from various 
world parts with different ecology backgrounds have been investigated and found to 
possess variety of therapeutic properties (Xu et al., 2004; Puglisi et al., 2007; Zubia 
et al., 2007), including Malaysia which is located right on the equatorial line (Lim, 
2005; Sasidharan, 2007).  The therapeutic properties are such as the antiviral activity; 
antibiotic activity; cytotoxicity, antimitogenic, anticancer and antitumor activities; 
